Hospital Sao Rafael
17
1
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 17 trials
100.0%
+13.5% vs industry average
6%
1 trials in Phase 3/4
9%
1 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Biperiden Trial for Epilepsy Prevention
Role: collaborator
Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure
Role: collaborator
Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients.
Role: collaborator
Assessment of Speckle Tracking Strain Predictive Value for Myocardial Fibrosis in Chagas Disease
Role: lead
The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.
Role: collaborator
Evaluation of G-CSF (Colony Stimulating Factor) in Patients With Chronic Chagas Cardiomyopathy
Role: lead
Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating
Role: collaborator
Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases
Role: lead
Autologous Mesenchymal Stem Cells Transplantation in Cervical Chronic and Complete Spinal Cord Injury
Role: lead
Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality
Role: lead
Galectin-3 as a Biomarker in Patients With Chagas Disease
Role: lead
Autologous Bone Marrow Stem Cell Transplantation in Patients With Spinal Cord Injury
Role: lead
Autologous Mesenchymal Stem Cells Transplantation in Thoracolumbar Chronic and Complete Spinal Cord Injury Spinal Cord Injury
Role: lead
Evaluation of Autologous Mesenchymal Stem Cell Transplantation in Chronic Spinal Cord Injury: a Pilot Study
Role: lead
Determination of Genetic Polymorphisms in Chronic Chagas Cardiomyopathy
Role: lead
Syndecan-4 as a Biomarker in Patients With Chagas Disease
Role: lead
MicroRNAs as Biomarkers in Patients With Chagas Disease
Role: lead
All 17 trials loaded